Endocrine disruptors and the male reproductive system

Best Pract Res Clin Endocrinol Metab. 2021 Sep;35(5):101567. doi: 10.1016/j.beem.2021.101567. Epub 2021 Aug 14.

Abstract

In recent years, there has been an increased incidence in several of the most common reproductive disorders, including hypospadias and cryptorchidism in newborns, and testicular cancer and lower sperm quality in young adult males. In addition, the timing of puberty has also changed over time. Although the cause of these reproductive effects is a matter of intense debate, a link with the presence of ubiquitous compounds in the environment, or the exposure to specific groups of medications during foetal life, has been suggested. Results from epidemiological and experimental studies, as well as clinical observations in humans indicate that endocrine-disrupting chemicals may be associated with those disorders. In this review, we will summarize the results of epidemiological studies and experimental studies utilising human testicular cells or tissue. Due to increasing public interest and the recently published data, the main focus will be on the effects of prenatal exposure to mild analgesics.

Keywords: analgesics; foetal development; germ cells; infertility; puberty; sperm.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cryptorchidism* / chemically induced
  • Cryptorchidism* / epidemiology
  • Endocrine Disruptors* / adverse effects
  • Endocrine Disruptors* / toxicity
  • Female
  • Genitalia, Male
  • Humans
  • Infant, Newborn
  • Male
  • Neoplasms, Germ Cell and Embryonal*
  • Pregnancy
  • Testicular Neoplasms* / chemically induced
  • Testicular Neoplasms* / epidemiology

Substances

  • Endocrine Disruptors